Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.48 USD | -5.17% | +1.96% | +51.41% |
02/05 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
02/05 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.41% | 2.55B | |
+75.36% | 12.54B | |
-23.21% | 7.71B | |
+7.67% | 6.72B | |
+13.59% | 5.38B | |
+34.82% | 4.89B | |
-15.69% | 4.71B | |
-25.08% | 3.75B | |
-26.56% | 2.77B | |
+0.25% | 2.05B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Wells Fargo Adjusts NovoCure's Price Target to $49 From $102, Keeps Overweight Rating